Clinical Trials · NCT03940742
A Study of Tirzepatide in Participants With Impaired Liver Function
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 32
- Start date
- Jul 2019
- Locations
- 3 sites, United States
- Primary endpoint
- Pharmacokinetics (PK): Area Under The Drug Concentration-Time Curve From Zero To Infinity (AUC[0-∞]) of Tirzepatide